Murphy & Mullick Capital Management Corp Ishares Tr Genomics Immunology Transaction History

Murphy & Mullick Capital Management Corp

  • $135 Billion
  • Q3 2025

A detailed history of Murphy & Mullick Capital Management Corp transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 275 shares of IDNA stock, worth $7,180. This represents 0.01% of its overall portfolio holdings.

Number of Shares
275
Previous 275 -0.0%
Holding current value
$7,180
Previous $5.64 Million 22.93%
% of portfolio
0.01%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$22.38 - $25.53 $6,154 - $7,020
275 New
275 $6.22 Million

Others Institutions Holding IDNA

# of Institutions
60
Shares Held
2.11M
Call Options Held
0
Put Options Held
0
View Full List

About ISHARES TR GENOMICS IMMUNOLOGY

IDNA Quotes by TradingView
  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Murphy & Mullick Capital Management Corp Portfolio

Follow Murphy & Mullick Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy & Mullick Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Murphy & Mullick Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email